Literature DB >> 18615142

L-acetylcarnitine: a proposed therapeutic agent for painful peripheral neuropathies.

S Chiechio1, A Copani, F Nicoletti, R W Gereau.   

Abstract

During the past two decades, many pharmacological strategies have been investigated for the management of painful neuropathies. However, neuropathic pain still remains a clinical challenge. A combination of therapies is often required, but unfortunately in most cases adequate pain relief is not achieved. Recently, attention has been focused on the physiological and pharmacological effects of L-acetylcarnitine in neurological disorders. There are a number of reports indicating that L-acetylcarnitine can be considered as a therapeutic agent in neuropathic disorders including painful peripheral neuropathies. In this review article, we will examine the antinociceptive and the neuroprotective effects of Lacetylcarnitine as tested in clinical studies and in animal models of nerve injury.

Entities:  

Keywords:  L-acetylcarnitine; antinociception; neuropathic pain; peripheral neuropathies

Year:  2006        PMID: 18615142      PMCID: PMC2430690          DOI: 10.2174/157015906778019509

Source DB:  PubMed          Journal:  Curr Neuropharmacol        ISSN: 1570-159X            Impact factor:   7.363


  56 in total

1.  Cloning and characterization of murine carnitine acetyltransferase: evidence for a requirement during cell cycle progression.

Authors:  S Brunner; K Kramar; D T Denhardt; R Hofbauer
Journal:  Biochem J       Date:  1997-03-01       Impact factor: 3.857

Review 2.  Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.

Authors:  Søren H Sindrup; Troels S Jensen
Journal:  Pain       Date:  1999-12       Impact factor: 6.961

Review 3.  Neuronal plasticity: increasing the gain in pain.

Authors:  C J Woolf; M W Salter
Journal:  Science       Date:  2000-06-09       Impact factor: 47.728

4.  Anti-apoptotic effect of acetyl-l-carnitine and I-carnitine in primary cultured neurons.

Authors:  T Ishii; Y Shimpo; Y Matsuoka; K Kinoshita
Journal:  Jpn J Pharmacol       Date:  2000-06

5.  Nerve growth factor binding in aged rat central nervous system: effect of acetyl-L-carnitine.

Authors:  L Angelucci; M T Ramacci; G Taglialatela; C Hulsebosch; B Morgan; K Werrbach-Perez; R Perez-Polo
Journal:  J Neurosci Res       Date:  1988-08       Impact factor: 4.164

6.  Autonomic neuropathy in streptozotocin diabetic rats: effect of acetyl-L-carnitine.

Authors:  Pietro Lo Giudice; Antonia Careddu; Giuseppina Magni; Teresa Quagliata; Licia Pacifici; Paolo Carminati
Journal:  Diabetes Res Clin Pract       Date:  2002-06       Impact factor: 5.602

7.  L-Acetylcarnitine induces analgesia by selectively up-regulating mGlu2 metabotropic glutamate receptors.

Authors:  S Chiechio; A Caricasole; E Barletta; M Storto; M V Catania; A Copani; M Vertechy; R Nicolai; M Calvani; D Melchiorri; F Nicoletti
Journal:  Mol Pharmacol       Date:  2002-05       Impact factor: 4.436

8.  Acetyl-L-carnitine corrects the altered peripheral nerve function of experimental diabetes.

Authors:  S Lowitt; J I Malone; A F Salem; J Korthals; S Benford
Journal:  Metabolism       Date:  1995-05       Impact factor: 8.694

Review 9.  Peripheral neuropathy with nucleoside antiretrovirals: risk factors, incidence and management.

Authors:  G J Moyle; M Sadler
Journal:  Drug Saf       Date:  1998-12       Impact factor: 5.606

10.  Systemic acetyl-L-carnitine eliminates sensory neuronal loss after peripheral axotomy: a new clinical approach in the management of peripheral nerve trauma.

Authors:  Andrew McKay Hart; Mikael Wiberg; Mike Youle; Giorgio Terenghi
Journal:  Exp Brain Res       Date:  2002-05-04       Impact factor: 1.972

View more
  12 in total

Review 1.  L-Carnitine and Acetyl-L-carnitine Roles and Neuroprotection in Developing Brain.

Authors:  Gustavo C Ferreira; Mary C McKenna
Journal:  Neurochem Res       Date:  2017-05-16       Impact factor: 3.996

Review 2.  Mitotoxicity in distal symmetrical sensory peripheral neuropathies.

Authors:  Gary J Bennett; Timothy Doyle; Daniela Salvemini
Journal:  Nat Rev Neurol       Date:  2014-05-20       Impact factor: 42.937

3.  Cellular stress responses, mitostress and carnitine insufficiencies as critical determinants in aging and neurodegenerative disorders: role of hormesis and vitagenes.

Authors:  Vittorio Calabrese; Carolin Cornelius; Anna Maria Giuffrida Stella; Edward J Calabrese
Journal:  Neurochem Res       Date:  2010-11-13       Impact factor: 3.996

4.  Neuroprotective Effects of Acetyl-L-Carnitine on Neonatal Hypoxia Ischemia-Induced Brain Injury in Rats.

Authors:  Shiyu Tang; Su Xu; Xin Lu; Rao P Gullapalli; Mary C McKenna; Jaylyn Waddell
Journal:  Dev Neurosci       Date:  2017-02-23       Impact factor: 2.984

Review 5.  Acetyl-L-carnitine in neuropathic pain: experimental data.

Authors:  Santina Chiechio; Agata Copani; Robert W Gereau; Ferdinando Nicoletti
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

6.  Transcriptional regulation of metabotropic glutamate receptor 2/3 expression by the NF-kappaB pathway in primary dorsal root ganglia neurons: a possible mechanism for the analgesic effect of L-acetylcarnitine.

Authors:  Santina Chiechio; Agata Copani; Laura De Petris; Maria Elena P Morales; Ferdinando Nicoletti; Robert W Gereau
Journal:  Mol Pain       Date:  2006-06-09       Impact factor: 3.395

Review 7.  Acetyl-L-carnitine in the treatment of peripheral neuropathic pain: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Sheyu Li; Qianrui Li; Yun Li; Ling Li; Haoming Tian; Xin Sun
Journal:  PLoS One       Date:  2015-03-09       Impact factor: 3.240

8.  HDAC and HAT inhibitors differently affect analgesia mediated by group II metabotropic glutamate receptors.

Authors:  Magda Zammataro; Maria Angela Sortino; Carmela Parenti; Robert W Gereau; Santina Chiechio
Journal:  Mol Pain       Date:  2014-11-18       Impact factor: 3.395

9.  Metabolomic profile and nucleoside composition of Cordyceps nidus sp. nov. (Cordycipitaceae): A new source of active compounds.

Authors:  Juan Chiriví; Giovanna Danies; Rocio Sierra; Nicolas Schauer; Sandra Trenkamp; Silvia Restrepo; Tatiana Sanjuan
Journal:  PLoS One       Date:  2017-06-21       Impact factor: 3.240

10.  Efficacy and Safety of the Combination of Superoxide Dismutase, Alpha Lipoic Acid, Vitamin B12, and Carnitine for 12 Months in Patients with Diabetic Neuropathy.

Authors:  Triantafyllos Didangelos; Eleni Karlafti; Evangelia Kotzakioulafi; Zisis Kontoninas; Charalampos Margaritidis; Parthena Giannoulaki; Konstantinos Kantartzis
Journal:  Nutrients       Date:  2020-10-23       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.